ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

XGN Exagen Inc

1.40
0.015 (1.08%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Exagen Inc XGN NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.015 1.08% 1.40 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.38 1.3606 1.42 1.40 1.385
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
30/4/202415:05GLOBEExagen to Announce First Quarter 2024 Results on May 13,..
26/4/202407:30GLOBEExagen Inc. Announces Changes to the Board of Directors
18/3/202407:00GLOBEExagen Inc. Reports Strong Fourth Quarter and Full-Year 2023..
18/3/202406:12IHMARKETNEWSAnticipation Builds on Wall Street for Federal Reserve’s..
08/3/202408:00GLOBEExagen Inc. to Participate in the KeyBanc Capital..
07/3/202415:05GLOBEExagen to Announce Fourth Quarter 2023 and Full-Year..
06/3/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202415:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202415:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202415:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202406:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202415:35EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202414:16EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
30/1/202415:05GLOBEExagen Inc. to Participate in the 2024 BTIG MedTech, Digital..
22/1/202415:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/1/202407:00EDGAR2Form 8-K - Current report
07/1/202411:00GLOBEExagen Inc. Announces Select Preliminary Full-Year 2023..
11/12/202315:05EDGAR2Form 8-K - Current report
29/11/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
29/11/202316:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
27/11/202315:05EDGAR2Form S-3/A - Registration statement under Securities Act of..
20/11/202307:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/11/202315:30EDGAR2Form 8-K - Current report
17/11/202315:06EDGAR2Form S-3 - Registration statement under Securities Act of..
13/11/202316:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202315:05EDGAR2Form 8-K - Current report
13/11/202315:05GLOBEExagen Inc. Reports Strong Third Quarter 2023 Results
09/11/202315:05GLOBEExagen Inc. and Johns Hopkins University Announce License..
02/11/202315:05GLOBEExagen Inc. to Participate in the 2023 Canaccord Genuity..
30/10/202315:05GLOBEExagen to Announce Third Quarter 2023 Financial Results on..
18/10/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202313:50DJNExagen Agrees to Pay Over $650K to Resolve Kickback..
28/9/202315:05GLOBEExagen Announces Acceptance of Multiple Abstracts at ACR..
12/9/202315:05GLOBEExagen Inc. to Participate in the 2023 Cantor Fitzgerald..
06/9/202316:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202308:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202307:00EDGAR2Form 8-K - Current report
07/8/202307:00GLOBEExagen Inc. Reports Strong Second Quarter 2023 Results
26/7/202315:05GLOBEExagen Inc. to Participate in the Canaccord Genuity 43rd..
25/7/202315:05GLOBEExagen to Announce Second Quarter 2023 Financial Results on..
24/7/202315:05EDGAR2Form 8-K - Current report
24/7/202315:05GLOBEExagen Inc. Appoints Paul Kim to Board of Directors
30/5/202308:00GLOBEExagen Inc. to Participate in the William Blair 43rd Annual..
15/5/202315:05GLOBEExagen Inc. Reports First Quarter 2023 Results

Su Consulta Reciente

Delayed Upgrade Clock